Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Lesaffer, G.
Right arrow Articles by Vanholder, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lesaffer, G.
Right arrow Articles by Vanholder, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2003) 18: 1299-1306
© 2003 European Renal Association-European Dialysis and Transplant Association

Urinary excretion of the uraemic toxin p-cresol in the rat: contribution of glucuronidation to its metabolization

Gerrit Lesaffer1,, Rita De Smet1, Frans M. Belpaire2, Bruno Van Vlem1, Marijn Van Hulle3, Rita Cornelis3, Norbert Lameire1 and Raymond Vanholder1

1 Renal Division and 2 Department of Pharmacology, Heymans Institute, University Hospital and 3 Laboratory of Analytical Chemistry, University of Gent, Gent, Belgium

Background. Increasing evidence indicates that lipophilic and/or protein-bound substances such as p-cresol are responsible for adverse physiological alterations in uraemic patients. To better understand the evolution of p-cresol disposition in renal failure and dialysis patients, it is necessary to determine its kinetic characteristics and biotransformation pathways.

Methods. We studied the biotransformation of p-cresol after intravenous injection of the compound in eight rats with normal renal function. Urine was collected in four 1 h intervals. To evaluate the presence of p-cresol metabolites, ß-glucuronidase was added to urine samples and the isolated unidentified chromatographic peak observed in previous experiments was submitted to tandem mass spectrometry (MS/MS) analysis.

Results. Administration of p-cresol produced a p-cresol peak and an unknown peak, suggesting biotransformation of the compound. Addition of ß-glucuronidase to urine samples and incubation at 37°C resulted in a marked decrease in the unidentified peak height (P<0.001) together with an increase in p-cresol peak height (P<0.001), suggesting that the unidentified peak was composed, at least in part, of p-cresylglucuronide. Mass spectrometry (MS) and MS/MS analysis of the isolated unidentified peak confirmed the presence of p-cresylglucuronide. Linear regression between the peak height of p-cresylglucuronide before enzyme treatment and the increase in p-cresol peak height after enzyme treatment in samples incubated with ß-glucuronidase allowed us to calculate the amount of p-cresylglucuronide as its p-cresol equivalents. This revealed that 64% of the injected p-cresol was excreted as glucuronide. There was no change in peak heights when sulphatase was added to the urine. When p-cresol and p-cresylglucuronide levels were combined, ~85% of all administered p-cresol was recovered in the urine. In addition, the combined urinary excretion of p-cresol and p-cresylglucuronide was more than four times greater than excretion of p-cresol by itself (P<0.01).

Conclusions. In rats with normal renal function, intravenous administration of p-cresol results in immediate and extensive metabolization of the compound into p-cresylglucuronide. The elimination of p-cresol from the body depends largely on the urinary excretion of this metabolite.

Keywords: creatinine; glucuronidation; kinetics; metabolization; p-cresol; rats

Correspondence and offprint requests to: Gerrit Lesaffer, Analytical Chemistry, KAHO Sint-Lieven, Gildestraat 17, Gent, Belgium. Email: gerrit.lesaffer{at}kahosl.be


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
A. W. Martinez, N. S. Recht, T. H. Hostetter, and T. W. Meyer
Removal of P-Cresol Sulfate by Hemodialysis
J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3430 - 3436.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
H. de Loor, B. Bammens, P. Evenepoel, V. De Preter, and K. Verbeke
Gas Chromatographic-Mass Spectrometric Analysis for Measurement of p-Cresol and Its Conjugated Metabolites in Uremic and Normal Serum
Clin. Chem., August 1, 2005; 51(8): 1535 - 1538.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
T. W. Meyer, E. C. Leeper, D. W. Bartlett, T. A. Depner, Y. Z. Lit, C. R. Robertson, and T. H. Hostetter
Increasing Dialysate Flow and Dialyzer Mass Transfer Area Coefficient to Increase the Clearance of Protein-bound Solutes
J. Am. Soc. Nephrol., July 1, 2004; 15(7): 1927 - 1935.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.